Literature DB >> 15775836

Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

Elaine Yeung1, Elaine Yong, Florence Wong.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15775836      PMCID： PMC1480573     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  115 in total

1.  Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction.

Authors:  B Afessa; P S Kubilis
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

2.  Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Authors:  V Gülberg; M Bilzer; A L Gerbes
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

3.  Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis.

Authors:  M Deschênes; J P Villeneuve
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

4.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.

Authors:  W Wong; P Liu; L Blendis; F Wong
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

Review 6.  Renal failure in liver disease.

Authors:  K U Eckardt
Journal:  Intensive Care Med       Date:  1999-01       Impact factor: 17.440

7.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

8.  Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Authors:  P Angeli; R Volpin; G Gerunda; R Craighero; P Roner; R Merenda; P Amodio; A Sticca; L Caregaro; A Maffei-Faccioli; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

9.  Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.

Authors:  S Møller; E F Hansen; U Becker; K Brinch; J H Henriksen; F Bendtsen
Journal:  Liver       Date:  2000-02

Review 10.  Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.

Authors:  V Arroyo; W Jiménez
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083
View more
  4 in total

1.  Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.

Authors:  Abolhassan Shakeri; Mojtaba Varshochi; Naser Atapour; Masoud Nemati; Manoochehr Khoshbaten; Daniel Fadaei Fouladi
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

2.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

Review 3.  Kidneys in chronic liver diseases.

Authors:  Marek Hartleb; Krzysztof Gutkowski
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

4.  The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.

Authors:  Virender Kumar; Yuxiang Dong; Vinod Kumar; Saud Almawash; Ram I Mahato
Journal:  Theranostics       Date:  2019-10-12       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.